Identification of potential novel targets for treating inflammatory bowel disease using Mendelian randomization analysis
Six proteins (FCGR2A, IL18R1, MST1, HGFAC, IL12B, and ANGPTL3) were identified as potential drug targets for the treatment of IBD and its subtypes.
Authors
- Jin‐Heng Gan
- Ji‐Chang Fan
- Yuan Lü (ORCID: https://orcid.org/0000-0002-2420-4804)
- Hao Lu (ORCID: https://orcid.org/0000-0003-0526-8172)
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- International Journal of Colorectal Disease
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1007/s00384-024-04744-2
- Citations
- 10
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 4.04